Ethiopian long-distance runner Gudaf Tsegay, a two-time world champion and Olympic medallist, has been handed a four-month doping ban by track and field authorities. The suspension, announced on Friday, effectively brings her 2024 season to an early close, preventing her from competing in major events for the remainder of the year.
The Athletics Integrity Unit (AIU) confirmed that the 29-year-old athlete, who previously held the indoor world record for the women’s 1,500 metres, tested positive for Letrozole last December. The AIU clarified that Tsegay had failed to seek prior permission for a medication used to manage a diagnosed health condition. While she subsequently provided comprehensive medical documentation, the AIU acknowledged that a Therapeutic Use Exemption (TUE) would have been granted had it been requested in advance of the positive test.
Letrozole is a substance commonly used in the treatment of breast cancer, particularly in postmenopausal women. It can also be utilised to manage the side effects associated with steroid use. The AIU's decision underscores the strict regulations surrounding medication use in elite sport, even when a legitimate medical need is present. Athletes are required to apply for TUEs before using prohibited substances, ensuring fairness and preventing any potential performance enhancement.
The four-month ban, which extends until September, means Tsegay will be absent from all forthcoming Diamond League meetings, a series of prestigious athletics competitions. She will also miss the inaugural Ultimate Championships, scheduled to take place in Budapest from 11-13 September. This represents a significant disruption to her competitive calendar, particularly following her participation in the 2024 Paris Olympics where she competed in the 1,500m, 5,000m, and 10,000m events, though she did not secure a medal.
Tsegay boasts an impressive career, including world championship titles in the 5,000 metres in 2022 and the 10,000 metres in 2023. She also secured an Olympic bronze medal in the 5,000 metres at the Tokyo Games in 2021. Her absence from the latter part of the season will be keenly felt in the world of athletics, depriving fans of seeing one of the sport's most decorated long-distance runners compete.
This incident highlights the ongoing challenges faced by anti-doping organisations in balancing athlete welfare with the integrity of sport. The case of Italian tennis player Sara Errani, who received a ban in 2017 for the same substance, serves as a precedent for the strict application of these rules across different sporting disciplines.
Source: Athletics Integrity Unit (AIU)